Pluristem Therapeutics (PSTI) Plans Public Offering of Common Stock and Warrants, and Concurrent Registered Direct Offering of Common Stock
April 3, 2019 4:52 PM
Pluristem Therapeutics Inc. (Nasdaq: PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy product candidates, announced today that ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
